Biblio
2023
McMillan A, Basu S, Karunanithi K, Parkins E, Lau EYan Ming, Cook G, Parrish C, Al-Kaisi F, Pratt G, Shafeek S, et al. Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. Br J Haematol. 2023.
Nesr G, Shah R, Kyriakou C, Sive J, Popat R, Yong K, Wisniowski B, Xu K, Wechalekar A, Lee L, et al. Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience. Leuk Lymphoma. 2023:1-7.